Sepsis Diagnostics Market
Sepsis Diagnostics Market Size Worth $1,255.14 Million by 2034 |
CAGR: 7.0%
Sepsis Diagnostics Market Size, Share, Trends, Industry Analysis Report:
By Product (Instrument, Blood Culture Media, Assay Kits & Reagents,
and Software), Technology, Testing Type, End User, Pathogen, and
Region (North America, Europe, Asia Pacific, Latin America, and Middle
East & Africa) – Market Forecast, 2025–2034
S
e
p
s
i
s
D
i
a
g
n
o
s
t
https://www.polarismarketresearch.com/industry-analysis/global-sepsis-diagnostics-market/request-for-sample
Sepsis Diagnostics Market
• The sepsis diagnostics market size was valued at USD 639.55 million
in 2024. The market is projected to grow from USD 682.72 million in
2025 to USD 1,255.14 million by 2034, exhibiting a CAGR of 7.0%
during 2025–2034.
Request To Sample :
https://www.polarismarketresearch.com/industry-analysis/global-
sepsis-diagnostics-market/request-for-sample
Sepsis Diagnostics Market
• Key Market Players :
• Abbott Laboratories
• ACON Laboratories
• BD (Becton, Dickinson and Company)
• Beckman Coulter
• BioMérieux
• Cepheid
• Danaher Corporation
• Hologic
• LumiraDx
• QIAGEN
• Roche Diagnostics
https://www.polarismarketresearch.com/buy/4470/2
Sepsis Diagnostics Market
Sepsis Diagnostics Market Market Report Highlights
• By product, the assay kits and reagents segment hold the largest sepsis diagnostics market share
due to their essential role in sepsis detection, with increasing demand for rapid diagnostic solutions
driving their adoption. The software segment is the highest growing, driven by the integration of AI
and machine learning for faster and more accurate diagnostics.
• Based on technology, the microbiology segment dominates the sepsis diagnostics market revenue
share due to its broad use in routine diagnostics, especially blood cultures. However, the molecular
diagnostics segment is registering the highest growth, driven by advancements in PCR and next-
generation sequencing for rapid and precise pathogen identification.
• By testing type, the laboratory testing segment holds a larger share, as it provides accurate, detailed
results using established diagnostic methods. The point-of-care testing segment is a faster-growing
segment fueled by the demand for rapid and accessible diagnostics in emergency and critical care
settings.
Buy Now :
https://www.polarismarketresearch.com/buy/4470/2
Sepsis Diagnostics Market Size Worth $1,255.14 Million by 2034 |
CAGR: 7.0%
Sepsis Diagnostics Market Size, Share, Trends, Industry Analysis Report:
By Product (Instrument, Blood Culture Media, Assay Kits & Reagents,
and Software), Technology, Testing Type, End User, Pathogen, and
Region (North America, Europe, Asia Pacific, Latin America, and Middle
East & Africa) – Market Forecast, 2025–2034
S
e
p
s
i
s
D
i
a
g
n
o
s
t
https://www.polarismarketresearch.com/industry-analysis/global-sepsis-diagnostics-market/request-for-sample
Sepsis Diagnostics Market
• The sepsis diagnostics market size was valued at USD 639.55 million
in 2024. The market is projected to grow from USD 682.72 million in
2025 to USD 1,255.14 million by 2034, exhibiting a CAGR of 7.0%
during 2025–2034.
Request To Sample :
https://www.polarismarketresearch.com/industry-analysis/global-
sepsis-diagnostics-market/request-for-sample
Sepsis Diagnostics Market
• Key Market Players :
• Abbott Laboratories
• ACON Laboratories
• BD (Becton, Dickinson and Company)
• Beckman Coulter
• BioMérieux
• Cepheid
• Danaher Corporation
• Hologic
• LumiraDx
• QIAGEN
• Roche Diagnostics
https://www.polarismarketresearch.com/buy/4470/2
Sepsis Diagnostics Market
Sepsis Diagnostics Market Market Report Highlights
• By product, the assay kits and reagents segment hold the largest sepsis diagnostics market share
due to their essential role in sepsis detection, with increasing demand for rapid diagnostic solutions
driving their adoption. The software segment is the highest growing, driven by the integration of AI
and machine learning for faster and more accurate diagnostics.
• Based on technology, the microbiology segment dominates the sepsis diagnostics market revenue
share due to its broad use in routine diagnostics, especially blood cultures. However, the molecular
diagnostics segment is registering the highest growth, driven by advancements in PCR and next-
generation sequencing for rapid and precise pathogen identification.
• By testing type, the laboratory testing segment holds a larger share, as it provides accurate, detailed
results using established diagnostic methods. The point-of-care testing segment is a faster-growing
segment fueled by the demand for rapid and accessible diagnostics in emergency and critical care
settings.
Buy Now :
https://www.polarismarketresearch.com/buy/4470/2